NCT04803201 2026-06-02Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell LymphomaAlliance for Clinical Trials in OncologyPhase 2 Suspended170 enrolled
NCT06692452 2026-04-01Tazemetostat Plus CHOP in 1L T-cell LymphomaDana-Farber Cancer InstitutePhase 2 Withdrawn